The post Curve Finance Warns PancakeSwap About Licensing Violation appeared on BitcoinEthereumNews.com. The team behind the Curve Finance decentralized finance (The post Curve Finance Warns PancakeSwap About Licensing Violation appeared on BitcoinEthereumNews.com. The team behind the Curve Finance decentralized finance (

Curve Finance Warns PancakeSwap About Licensing Violation

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

The team behind the Curve Finance decentralized finance (DeFi) platform accused the PancakeSwap decentralized exchange (DEX) of using its code without the proper licensing.

The code is tied to the “StableSwap” feature used for swapping stablecoins and “tightly-pegged” assets on PancakeSwap Infinity, the latest version of the PancakeSwap DEX.

“If you want to enjoy using stableswap without legal problems and to borrow some of our expertise to keep users SAFU, you still can contact us for licensing and collaboration,” the Curve team said on X.

Source: Curve Finance

In a separate post, Curve said “deep stableswap expertise” is needed to safely integrate swap features, and cited the 2022 hack of the Saddle Finance DEX and the $116 million hack of DeFi protocol Balancer in 2025 as examples of swap-based code exploits.

The PancakeSwap team said it would reach out to Curve Finance to discuss the issue. “Indeed, better to be friends and build together,” the Curve team responded.

Cointelegraph reached out to both teams but did not receive a response by the time of publication.

The incident highlights the potential cybersecurity and legal issues that arise in decentralized finance as projects and protocols continue to iterate on products and expand features.

Related: Curve founder says DeFi must ditch token emissions for real revenue

PancakeSwap Infinity launches and goes cross-chain

PancakeSwap Infinity launched on the Arbitrum network and BNB Chain in April 2025, following the integration of one-click, cross-chain swaps that allow users to move digital assets between blockchain protocols.

The updated DEX introduced “hooks,” smart contract plug-ins that customize parameters for liquidity pools, including dynamic fee structuring, tailored rebates and onchain limit orders that execute when preset conditions are met.

Different types of liquidity pools on PancakeSwap Infinity. Source: PancakeSwap

The upgrade also lowered pool creation fees by up to 99% and was built to accommodate different liquidity strategies, according to PancakeSwap.

In July 2025, PancakeSwap Infinity launched on Base, an Ethereum layer-2 (L2) scaling network, and touted up to 50% cheaper trading fees when Ether (ETH), the native token of the Ethereum layer-1 blockchain network, was traded against ERC-20 tokens.

ERC-20 is the token standard for most assets minted on Ethereum, including the gas and governance tokens of Ethereum L2s, memecoins, and other projects issuing tokens on Ethereum.

Magazine: MakerDAO’s plan to bring back ‘DeFi summer’ — Rune Christensen

Cointelegraph is committed to independent, transparent journalism. This news article is produced in accordance with Cointelegraph’s Editorial Policy and aims to provide accurate and timely information. Readers are encouraged to verify information independently. Read our Editorial Policy https://cointelegraph.com/editorial-policy

Source: https://cointelegraph.com/news/curve-accuses-pancakeswap-copy-code?utm_source=rss_feed&utm_medium=feed&utm_campaign=rss_partner_inbound

Market Opportunity
DeFi Logo
DeFi Price(DEFI)
$0.000355
$0.000355$0.000355
+11.63%
USD
DeFi (DEFI) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09